London New Drugs Group (LNDG)
The London New Drugs Group (LNDG) is aimed at healthcare professionals who require a detailed summary of the clinical trial information and discussion points or recommendations for use as well as the cost implications of new drugs. LNDG documents are produced for use within the NHS and must not be reproduced for commercial purposes. Any technology appraisal produced by NICE automatically supersedes a LNDG review written on that subject.
The website provides access to:
-
Guidance and Briefing documents.
-
Updates: These are produced every two months.
-
LNDG Database of recent and imminent new drug launches.
-
Link to "Notes on Drug Developments with potential financial implications for SAFF Round 2003-2005".
-
Links to a range of other databases and websites.
-
A feedback section, where comments on documents as well as suggestions for new drug reviews can be posted.
Network website: www.londonpharmacy.nhs.uk/LNDG
Network contact: Alex Topol, alexandra.topol@nwlh.nhs.uk, tel. 020 8869 3551